MINNEAPOLIS--(BUSINESS WIRE)--Possis Medical, Inc. (NASDAQ:POSS) today announced that it will showcase its AngioJet® Ultra Console, now pending approval from the U.S. Food and Drug Administration (FDA), as well as the recently market-cleared GuardDOG® Occlusion System and Fetch™ Aspiration Catheter, at the 2006 Transcatheter Cardiovascular Therapeutics (TCT) conference in Washington D.C., October 22-27. In addition, Dr. Georgios Sianos of the Thoraxcentre in Rotterdam, the Netherlands, is presenting compelling results showing the clinical value of AngioJet treatment for coronary thrombus at TCT on Monday, October 23. Possis also is hosting two thrombus management breakfast sessions.
